Marcel Sandberg • 1969 • Jar • 9 roles • 15 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C CARBOGEN AS	Managing Director/CEO	54,500	-92,565	100 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
P PINKMAN AS	Chairman	-	185,101,279	100 % directly
C CARBOGEN AS	Chairman	54,500	-92,565	100 % directly
S SYNTHCONSULT AS	Chairman	-	1,729,380	50 % indirectly
P PROTOS AS	Board Member	-	21,910	20 % indirectly
B BJØRGVIN THERAPEUTICS GROUP AS	Board Member	-	-46,641	8 % directly
T TRAMONTANE AS	Board Member	33,712,813	13,009,793	2 % directly
P PINKMAN DATTER AS Closed	Contact Person	-	-	-

Last update: Mar 24, 2025

Related industries

1

Industry and manufacturing
Process industry

Direct relationships

5

IR
Inger Reidun Fjeldskaar Aukrust1957
SYNTHCONSULT AS, BJØRGVIN THERAPEUTICS GROUP AS
PD
Pål Dahle1970
TRAMONTANE AS
CE
Chris Erik Mohn1972
TRAMONTANE AS
SS
Seema Singh1974
TRAMONTANE AS
BT
Bjørn Tore Gjertsen1966
BJØRGVIN THERAPEUTICS GROUP AS

Shares owned by Marcel Sandberg

Name	Share class	Total operating income	Total equity	Share
P PINKMAN AS	Ordinære aksjer	0	185,101,279	100 % directly
C CARBOGEN AS	Ordinære aksjer	54,500	-92,565	100 % directly
S SYNTHCONSULT AS		0	1,729,380	50 % indirectly
N NORDSJØ OPPORTUNITY AS		0	0	24.81 % indirectly
P PROTOS AS		0	21,910	20 % indirectly
D DEFIBRIO AS		0	224,134,352	8.33 % indirectly
B BJØRGVIN THERAPEUTICS GROUP AS	Ordinære aksjer	0	-46,641	8 % directly
K KECHU MIDCO AS		0	20,292,173	5.44 % indirectly
T TRAMONTANE AS	Ordinære aksjer	33,712,813	13,009,793	2 % directly
C CUBERA PRIVATE EQUITY 2025 INVEST AS		0	0	1.46 % indirectly
E ENERIN AS	Ordinære aksjer	4,162,280	167,120,453	0.05 % directly < 0.01 %
L LYTIX BIOPHARMA ASA	Ordinære aksjer	0	61,750,000	0.02 % directly < 0.01 %
A AMICOAT AS	Ordinære aksjer	4,139,375	9,270,321	< 0.01 % directly
P PHARMASUM THERAPEUTICS AS	Ordinære aksjer	0	0	< 0.01 % directly
P PHARMA HOLDINGS AS	Ordinære aksjer	2,889,281	14,055,041	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026